This cataract lens stock has gained 44% this year and over 200% since 2023. Analysts expect the company to turn profitable in 2024.
Five stocks that have been losing money are on the IBD 50 growth list because of strong sales growth. Most stocks do not have a base on their chart though.
Does RxSight, Inc. (RXST) have what it takes to be a top stock pick for momentum investors? Let's find out.